These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12550799)

  • 1. Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions.
    McDaid FM; Barker SA; Fitzpatrick S; Petts CR; Craig DQ
    Int J Pharm; 2003 Feb; 252(1-2):235-40. PubMed ID: 12550799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of components in drug formulations: a comparison between HPLC and DSC methods.
    Ceschel GC; Badiello R; Ronchi C; Maffei P
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1067-72. PubMed ID: 12899995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the use of stepwise isothermal high sensitivity DSC as a means of detecting drug-excipient incompatibility.
    Wissing S; Craig DQ; Barker SA; Moore WD
    Int J Pharm; 2000 Apr; 199(2):141-50. PubMed ID: 10802407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine besylate-excipients interaction in solid dosage form.
    Abdoh A; Al-Omari MM; Badwan AA; Jaber AM
    Pharm Dev Technol; 2004; 9(1):15-24. PubMed ID: 15000463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-excipient compatibility testing using a high-throughput approach and statistical design.
    Wyttenbach N; Birringer C; Alsenz J; Kuentz M
    Pharm Dev Technol; 2005; 10(4):499-505. PubMed ID: 16370179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy.
    Mura P; Faucci MT; Manderioli A; Bramanti G; Ceccarelli L
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):151-63. PubMed ID: 9863953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility studies of nateglinide with excipients in immediate release tablets.
    Pani NR; Nath LK; Acharya S
    Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
    Yoshida MI; Gomes EC; Soares CD; Oliveira MA
    Drug Dev Ind Pharm; 2011 Jun; 37(6):638-47. PubMed ID: 21449701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations.
    Mora PC; Cirri M; Mura P
    J Pharm Biomed Anal; 2006 Sep; 42(1):3-10. PubMed ID: 16574368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
    Balani PN; Ng WK; Tan RB; Chan SY
    J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
    Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
    J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-excipient interactions resulting from powder mixing. IV: Role of lubricants and their effect on in vitro dissolution.
    Chowhan ZT; Chi LH
    J Pharm Sci; 1986 Jun; 75(6):542-5. PubMed ID: 3735097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures.
    Tomassetti M; Catalani A; Rossi V; Vecchio S
    J Pharm Biomed Anal; 2005 Apr; 37(5):949-55. PubMed ID: 15862672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-excipient compatibility assessment of solid formulations containing meloxicam.
    da Silveira LM; Fiorot AB; Xavier TP; Yoshida MI; de Oliveira MA
    Eur J Pharm Sci; 2018 Jan; 112():146-151. PubMed ID: 29174987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of microthermal analysis and photothermal microspectroscopy as novel approaches to drug-excipient compatibility studies.
    Harding L; Qi S; Hill G; Reading M; Craig DQ
    Int J Pharm; 2008 Apr; 354(1-2):149-57. PubMed ID: 18162342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2004 May; 35(3):449-58. PubMed ID: 15137971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.